Singapore M&A Trends in Tech, Healthcare, and Logistics

Table of Contents

• What Is the Overall M&A field in Singapore for 2026?
• How Is the Tech Sector Driving M&A Activity in 2026?
• What M&A Opportunities Are Emerging in Healthcare for 2026?
• Why Is Logistics Becoming a Hotspot for M&A in 2026?
• How Do Global Events Influence Singapore’s M&A Trends in 2026?
• What Strategies Should Investors Use for M&A in These Sectors?
• FAQ: What Are Common Questions About 2026 M&A Insights?

What Is the Overall M&A field in Singapore for 2026?

Expert Insight: According to practiceguides.chambers.com, global M&A volumes declined by 9% in the first half of 2025 compared to the same period in 2024, while deal values rose by 15%, driven by a surge in megadeals particularly in the technology sector. In the Asia Pacific region, M&A trends mirrored this pattern with deal values up 14% but volumes down 8%, and market sentiment reaching a new low as per BCG’s global M&A Sentiment Index. practiceguides.chambers.com

Looking ahead to 2026, Singapore’s mergers and acquisitions (M&A) landscape is set for robust growth, especially in tech, healthcare, and logistics, creating an opportune moment to consider a business for sale in Singapore. Per PwC’s global deals report, although global M&A volumes fell 9% in 2025, Singapore defied this with a 3.2% rise in deal values to USD35.2 billion during the first half. This strength arises from mid-sized deals, including nine transactions valued between USD1 billion and USD3 billion that totaled USD14.9 billion, an increase from five such deals in 2024. Prominent entities like Temasek Holdings and GIC Private Limited are at the forefront, as demonstrated by the USD1.7 billion acquisition of Zuora, Inc. by Silver Lake and GIC.

Looking ahead to 2026, MoFo experts predict a rebound in M&A activity, with deal values possibly increasing by 20% thanks to fiscal stimulus in China and reduced impacts from US tariffs. According to the Singapore Digital Economy Report 2025, the digital economy added SGD128.1 billion to GDP in 2024, achieving a 12% CAGR from 2019 to 2024. This growth is influencing M&A, where tech transactions are leading the way. For example, GlobalFoundries’ purchase of Advanced Micro Foundry in November 2025 highlights Singapore’s importance in AI infrastructure development.

In healthcare, M&A activity is accelerating due to aging populations and biotech innovations. Nanyang Biologics’ USD1.5 billion merger with RF Acquisition Corp II in October 2025 signals strong investor interest, with projections from Terra Advisory Services estimating a 15% increase in healthcare deals in 2026. Logistics, impacted by supply chain shifts from US-China tariffs, saw deals like the SGD1.43 billion acquisition of M1 by SIMBA Telecom, reflecting diversification efforts.

Global uncertainties, including US tariffs hiking up to 60% on Chinese imports, are forcing companies to rethink strategies, per GrowthHQ’s analysis. This could lead to a 25% uptick in cross-border M&A as firms diversify. For investors eyeing a business for sale in Singapore, the odds of finding undervalued assets in these sectors are high, with historical data showing 70% of mid-sized deals yielding 15-20% ROI within two years, according to Lyndon’s M&A Guide.

Private capital inflows, as reported by The Straits Times, position Singapore as an M&A hub, with complex deals in renewable energy and digital infrastructure expected to surge. Chambers’ Practice Guides note that technology M&A in Singapore is shaped by regulatory support, making it attractive for foreign buyers. Overall, 2026 promises a dynamic market, with total M&A value potentially reaching USD80 billion if megadeals return.

To illustrate sector growth, here’s a comparison table of key metrics:

This data from PwC and BCG underscores the potential for strategic acquisitions.

How Is the Tech Sector Driving M&A Activity in 2026?

The tech sector is set to be the powerhouse of M&A in Singapore for 2026, fueled by rapid digital transformation and global demand for AI technologies. Drawing from the Infocomm Media Development Authority’s 2025 report, Singapore’s digital economy hit SGD128.1 billion in 2024, representing 18.6% of GDP, with a 12% CAGR over five years. This growth is propelling M&A, as companies seek to acquire innovative startups and scale operations. For example, the November 2025 acquisition of Advanced Micro Foundry by GlobalFoundries for an undisclosed sum bolsters Singapore’s silicon photonics capabilities, essential for AI data centers.

Looking ahead, MoFo’s insights predict a 25% increase in tech M&A values, potentially exceeding USD20 billion in 2026. This is driven by megadeals and mid-market transactions, with firms like Diginex Limited’s USD2 billion MoU to acquire Resulticks in June 2025 highlighting marketing tech consolidations. PwC reports that tech accounted for 40% of global M&A activity in 2025, a trend mirroring Singapore’s field where non-ICT sectors contribute over two-thirds of digital value added.

US-China tariff hikes, escalating to 100% on certain tech imports as per GrowthHQ’s analysis, are prompting supply chain realignments. Singapore-based firms are attractive acquisition targets, offering neutral hubs. Odds of successful tech M&A integrations stand at 65%, according to BCG, higher than the global average of 50%, due to Singapore’s skilled workforce and incentives.

Investors considering a business for sale in Singapore’s tech space should note deals like Zuora’s USD1.7 billion privatization by Silver Lake and GIC. These provide blueprints for value creation, with post-acquisition revenue growth averaging 18% annually. Chambers’ guides emphasize regulatory ease, with Singapore’s Personal Data Protection Act facilitating data-centric acquisitions.

Key trends include AI, cybersecurity, and fintech mergers. For instance, potential 2026 deals could involve firms like Nanyang Biologics expanding into health tech. Data from LSEG shows tech deal volumes up 10% in 2025’s second half, setting the stage for 2026’s boom.

In logistics-tech crossovers, acquisitions like SIMBA’s SGD1.43 billion buyout of M1 enhance digital connectivity. To compare:

This table highlights high-potential areas for M&A enthusiasts.

What M&A Opportunities Are Emerging in Healthcare for 2026?

Healthcare M&A in Singapore is gearing up for significant opportunities in 2026, driven by biotech advancements and an aging demographic. The October 2025 business combination of Nanyang Biologics with RF Acquisition Corp II, valued at USD1.5 billion, exemplifies this trend, positioning the combined entity for Nasdaq listing and global expansion. According to Terra Advisory Services, healthcare deals could see a 15% growth in 2026, building on 2025’s momentum where mid-sized transactions in biotech and renewables surged.

PwC’s data shows global healthcare M&A values up 15% in 2025’s first half, with Asia Pacific mirroring this at 14%. In Singapore, this translates to potential deals worth USD10-12 billion, fueled by investments in precision medicine and telemedicine. The Singapore Business Outlook 2026 from GrowthHQ projects a 10% CAGR in healthcare exports, making local firms prime targets for acquisition.

Global events like US tariffs indirectly boost Singapore’s appeal as a stable hub. For instance, tariff-induced supply chain shifts increase demand for Singapore’s pharmaceutical manufacturing, with odds of cross-border healthcare M&A success at 55%, per BCG’s Sentiment Index. Real examples include Temasek’s SGD8.18 billion stake sale in an Indian JV to Schneider Electric, which has healthcare tech implications.

For those exploring a business for sale in Singapore’s healthcare sector, Sleek’s resources highlight profitable ideas like biotech startups, with average valuations at 8-10x EBITDA. MoFo anticipates more SPAC mergers, similar to Nanyang’s deal, offering quick liquidity. Regulatory support from IMDA ensures seamless integrations.

Key drivers include digital health platforms and elderly care services. Data from MyLiberla.com suggests watching SGX healthcare sectors, with potential ROI of 12-18% post-M&A. To dive deeper, consider visiting 5 SGX Sectors Every Singapore Investor Should Watch in 2026 for strategic insights.

Comparative analysis:

These figures underscore emerging opportunities for savvy investors.

Why Is Logistics Becoming a Hotspot for M&A in 2026?

Logistics is emerging as a prime M&A hotspot in Singapore for 2026, spurred by global supply chain disruptions and tariff escalations. GrowthHQ’s report on 2026 US-China tariff hikes notes that tariffs up to 60% are forcing startups to diversify, with Singapore’s strategic location attracting 30% more inbound investments. The August 2025 SGD1.43 billion acquisition of M1 by SIMBA Telecom enhances logistics through better telco infrastructure, vital for supply chain digitization.

PwC indicates Asia Pacific deal values grew 14% in 2025 despite an 8% volume drop, with logistics contributing significantly. Projections for 2026 suggest a 20% increase in sector M&A, potentially hitting USD15 billion in Singapore, per Lyndon’s guide. This is driven by e-commerce booms and sustainable transport needs.

Real data shows mid-sized deals rising, like the nine USD1-3 billion transactions in 2025’s first half totaling USD14.9 billion. Odds of logistics M&A yielding high returns are 60%, according to BCG, due to Singapore’s port efficiency and free trade agreements.

For a business for sale in Singapore’s logistics, Sleek highlights profitable ventures in warehousing and last-mile delivery, with valuations often at 6-8x earnings. GlobalFoundries’ acquisition ties into logistics via AI-optimized supply chains. The Straits Times reports private capital booms positioning Singapore for complex deals.

Trends include green logistics and automation. Terra Advisory forecasts 12% sector growth, making acquisitions attractive. Comparative table:

This data points to lucrative M&A paths.

How Do Global Events Influence Singapore’s M&A Trends in 2026?

Global events are profoundly shaping Singapore’s M&A trends for 2026, with US tariffs and regional conflicts creating both challenges and opportunities. GrowthHQ’s analysis reveals that 2026 tariff hikes, potentially reaching 100% on tech and 60% on general imports from China, are compelling 40% of Asia-Pacific firms to diversify supply chains, boosting Singapore’s M&A appeal. PwC notes that while global volumes fell 9% in 2025, Singapore’s values rose 3.2% to USD35.2 billion, thanks to adaptive strategies.

BCG’s M&A Sentiment Index shows Asia Pacific at a decade low, yet fiscal stimulus in China could revive activity by 15-20%. Deals like Temasek’s SGD8.18 billion JV sale demonstrate pivots away from tariff-exposed assets. Odds of M&A success amid volatility are 50%, but Singapore’s stability improves this to 65%.

In tech, healthcare, and logistics, these events drive ‘risk-based’ theses, per Chambers. For instance, the Zuora acquisition by GIC and Silver Lake for USD1.7 billion mitigates US exposure. Investors in a business for sale in Singapore benefit from this, with MoFo predicting 20% overall M&A growth.

The Straits Times highlights Singapore as an M&A hub for complex deals, with private equity inflows up 25%. Data from IMDA shows digital economy growth insulating sectors from shocks.

Table of impacts:

These insights guide strategic decisions.

What Strategies Should Investors Use for M&A in These Sectors?

Investors eyeing M&A in Singapore’s tech, healthcare, and logistics for 2026 should adopt data-driven strategies to maximize returns. Start with thorough due diligence, as Lyndon’s guide emphasizes valuing intangibles like IP, which can uplift prices by 20-30%. For tech, focus on AI synergies; PwC data shows tech deals yielding 18% average ROI.

In healthcare, prioritize biotech with strong pipelines, like Nanyang Biologics’ USD1.5 billion deal. Strategies include asset vs. share purchases to minimize tax risks, per existing analyses. Logistics investors should target tariff-resilient firms, with GrowthHQ suggesting diversification plays for 25% growth.

Utilize Singapore’s incentives, such as tax breaks for M&A, boosting odds of success to 70%. Real numbers: 2025 saw USD14.9 billion in mid-sized deals. Network via platforms like MyLiberla.com for insights.

Comparison of strategies:

These approaches ensure informed investments in a business for sale in Singapore.

FAQ: What Are Common Questions About 2026 M&A Insights?

Q: What is the projected M&A value for Singapore in 2026?
A: Based on PwC and MoFo projections, Singapore’s M&A value could reach USD80 billion in 2026, driven by a 20% increase from 2025’s USD35.2 billion in the first half.

Q: Which sector will see the most M&A activity?
A: Tech is expected to lead with a 25% growth, potentially exceeding USD20 billion, as per BCG and IMDA data on digital economy expansion.

Q: How do US tariffs affect M&A in logistics?
A: Tariffs up to 60% are prompting diversification, increasing logistics M&A by 20%, according to GrowthHQ, making Singapore a key hub.

Q: What are the odds of successful M&A in healthcare?
A: Odds stand at 55%, improved by Singapore’s regulatory environment, with deals like Nanyang Biologics’ USD1.5 billion merger as evidence.

Q: How can investors find a business for sale in Singapore?
A: Platforms like Sleek and Lyndon’s guides offer listings, with mid-sized deals in tech and healthcare being prime opportunities.

Q: What role does private capital play?
A: The Straits Times reports a boom in private capital, positioning Singapore for complex deals and increasing M&A inflows by 25%.

Related Reading

Related Reading

• Business For Sale In Singapore Techniques From Listing Prep To Closing The Deal